ArticleActa oncologica (Stockholm, Sweden)2024
Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer - a nationwide, retrospective study.
Alan Celik et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.